2023-05-10
\(~\)
\(~\) As of: 2023-05-06
CANCER SCREENING DEFICIT
This chapter evaluates the disruption of screening medical services by COVID-19 by looking at effects on Gyn Cancer screening and Colorectal Cancer screening using FIT, between 2019-01-02 and 2023-05-06.
\(~\)
\(~\)
| scrn.encntr | period.2023 | period.2022 | period.2021 | period.2020 | period.2019 | deficit20 | deficit20.prcnt | deficit21 | deficit21.prcnt | deficit22 | deficit22.prcnt |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Breast Ca | 1728 | 3361 | 3112 | 2942 | 3677 | -735 | -19.99% | -565 | -15.37% | -316 | -8.59% |
| Gyn exam | 2385 | 4086 | 3154 | 2783 | 3443 | -660 | -19.17% | -289 | -8.39% | 643 | 18.68% |
| Cervical Ca | 460 | 365 | 427 | 273 | 287 | -14 | -4.88% | 140 | 48.78% | 78 | 27.18% |
| Colorectal | 1243 | 3599 | 3159 | 2430 | 2465 | -35 | -1.42% | 694 | 28.15% | 1134 | 46.00% |
| Note: | |||||||||||
|
period.2019 = encounters for year 2019, etc., deficit: based on pre-COVID full year (2019) encounters, Colorectal Ca screening was by FIT occult fecal blood method, Cervical Ca Screening using specific dx codes under-counts (subsumed in GYN exam), but trend holds. |
For Colorectal cancer screening, nearly all the patients do the FIT (self-administered card smear test) which bypasses regular office visit. This explains the lower deficit when compared to services that require in-person visit and interaction with the physician.